Adlai Nortye Group Statistics
NASDAQ: ANLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.55-0.51 (-5.63%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Adlai Nortye Group by the numbers
Adlai Nortye Group has a market capitalization of $550.6 million based on 58.73M shares outstanding. With trailing EPS of $-0.66, Adlai Nortye Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 31.2% below its 50-day average and 27.1% below its 200-day average.
Average daily trading volume is 244.74K shares, or about $2.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANL valuation vs. peer median
| Metric | ANL | Peer median | Difference |
|---|---|---|---|
| Market cap | $550.60M | $544.88M | +1% |
| Avg. volume | 244.74K | 1.28M | -81% |
Peer median across 8 companies: ACRS, AVBP, CBIO, BCAX, GERN, CLYM, DSGN, ZVRA.
Valuation
- Market cap
- $550.60M
- EPS (TTM)
- $-0.66
- Shares outstanding
- 58.73M
Price and trading
- Previous close
- 9.06
- Open
- 8.93
- Day range
- 8.36 – 9.11
- 52-week range
- 0.879 – 17.25
- 52-week change
- +533.33%
- Beta
- —
- Volume
- 380.64K
- Average volume
- 244.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 8, 2025
Additional statistics
- Market Cap
- 550.60M
- Forward Pe
- -29.05
- Eps
- -0.66
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.25
- Week52 Low
- 0.88
- Avg Volume
- 244.74K
- Shares Outstanding
- 58.73M
- Ma50
- 12.43
- Ma200
- 11.74
- Earnings Date
- Aug 8, 2025
- Pct From52w High
- -50.43%
- Pct From52w Low
- 872.70%